Active antiangiogenic therapy
Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiog...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
07.07.2009
|
Online Access | Get full text |
Cover
Loading…
Abstract | Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiogenesis.These procedures can be employed in the single or combined therapy for the treatment of cancer and its metastasis, acute and chronic inflammatory processes, infectious diseases, autoimmune diseases, diabetic and newborn retinopathies, organ transplant rejection, macular degeneration, neovascular glaucoma, hemangioma, and angiofibroma, among others. |
---|---|
AbstractList | Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiogenesis.These procedures can be employed in the single or combined therapy for the treatment of cancer and its metastasis, acute and chronic inflammatory processes, infectious diseases, autoimmune diseases, diabetic and newborn retinopathies, organ transplant rejection, macular degeneration, neovascular glaucoma, hemangioma, and angiofibroma, among others. |
Author | Vázquez Blomquist, Dania Marcia Lasa, Alexis Musachio Ocejo, Omar Lopez Romero, Mónica Bequet Gavilondo Cowley, Jorge Victor Silva Rodriguez, Ricardo de la Caridad Acevedo Castro, Boris Ernesto Fernández Molina, Luis Enrique Rodriguez, Ernesto Galban |
Author_xml | – sequence: 1 givenname: Mónica Bequet surname: Romero fullname: Romero, Mónica Bequet – sequence: 2 givenname: Boris Ernesto surname: Acevedo Castro fullname: Acevedo Castro, Boris Ernesto – sequence: 3 givenname: Jorge Victor surname: Gavilondo Cowley fullname: Gavilondo Cowley, Jorge Victor – sequence: 4 givenname: Luis Enrique surname: Fernández Molina fullname: Fernández Molina, Luis Enrique – sequence: 5 givenname: Omar Lopez surname: Ocejo fullname: Ocejo, Omar Lopez – sequence: 6 givenname: Ricardo de la Caridad surname: Silva Rodriguez fullname: Silva Rodriguez, Ricardo de la Caridad – sequence: 7 givenname: Alexis Musachio surname: Lasa fullname: Lasa, Alexis Musachio – sequence: 8 givenname: Ernesto Galban surname: Rodriguez fullname: Rodriguez, Ernesto Galban – sequence: 9 givenname: Dania Marcia surname: Vázquez Blomquist fullname: Vázquez Blomquist, Dania Marcia |
BookMark | eNrjYmDJy89L5WSQdUwuySxLVUjMK8lMzEvPzE9PzctMVijJSC1KLKjkYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDc1NTMwsDSmAglAJxFJxk |
ContentType | Patent |
CorporateAuthor | Centro De Ingenieria Genetica Y Biotechnologia |
CorporateAuthor_xml | – name: Centro De Ingenieria Genetica Y Biotechnologia |
DBID | EFH |
DatabaseName | USPTO Issued Patents |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EFH name: USPTO Issued Patents url: http://www.uspto.gov/patft/index.html sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
ExternalDocumentID | 07556809 |
GroupedDBID | EFH |
ID | FETCH-uspatents_grants_075568093 |
IEDL.DBID | EFH |
IngestDate | Sun Mar 05 22:31:21 EST 2023 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-uspatents_grants_075568093 |
OpenAccessLink | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7556809 |
ParticipantIDs | uspatents_grants_07556809 |
PatentNumber | 7556809 |
PublicationCentury | 2000 |
PublicationDate | 20090707 |
PublicationDateYYYYMMDD | 2009-07-07 |
PublicationDate_xml | – month: 07 year: 2009 text: 20090707 day: 07 |
PublicationDecade | 2000 |
PublicationYear | 2009 |
References | Prewett, Marie, et al., "Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors", Cancer Research 1999, 59:5209-5218. Rodriguez et al. (6149921) 20001100 Leggatt et al, J Immunology 161: 4728-4735, 1998. Kobrin et al, J Immunology 146: 2017-2020, 1991. Lu et al, J Biol Chemistry 275(19): 14321-14330, May 2000. Stacker et al, J Biol Chemistry 274(49): 34884-92, Dec. 1999. Siemeister et al, J Biol Chemistry 273(18): 11115-11120, 1998. Kendall et al. (5712380) 19980100 Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998. Davidoff, Andrew M., et al., "Bone Marrow-derived Cells Contribute to Tumor Neovasculature and, When Modified to Express an Angiogenesis Inhibitor, Can Restrict Tumor Growth in Mice", Clinical Cancer Research 2001, 7:2870-2879. (WO 99/45018) 19990900 Ngo et al., The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994. Wei, Yu-quan, et al., "Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen", PNAS 2001, 98(20):11545-11550. (WO 00/53219) 20000900 |
References_xml | – year: 20001100 ident: 6149921 contributor: fullname: Rodriguez et al. – year: 19990900 ident: WO 99/45018 – year: 19980100 ident: 5712380 contributor: fullname: Kendall et al. – year: 20000900 ident: WO 00/53219 |
Score | 2.739972 |
Snippet | Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and... |
SourceID | uspatents |
SourceType | Open Access Repository |
Title | Active antiangiogenic therapy |
URI | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7556809 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUlLSQRWREm6KeZGprqgM6R0k0yMU3VTjBJNjJKSky0TwUMXvn5mHqEmXhGmEUwMHvC9MLnAbKRbAHRLsV5pcUFJPnhxJbB4h0S8LuTwZ9AZgXmg0wfK83LyE1MCUtL0zUFHaYF28jFbGICW9rm6eXAzcAKNADbZ8kqKkSoNN0EGtgCwqBADU2qeCIOsI7hoUQB6BRgl6Zn5wKjLTFaAbICqFGVQcHMNcfbQhZsVn14EWqMSbwC101iMgQXYV0-VYFCwNE0yTLW0TDJPTjMxMUi0BLolxTARCAyTTVMMUo0kGSRxGiOFR06agQsyjQEaV5RhYCkpKk2VBdaGJUlyYK8CABgsavw |
link.rule.ids | 230,309,783,805,888,64367 |
linkProvider | USPTO |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUlLSQRWREm6KeZGprqgM6R0k0yMU3VTjBJNjJKSky0TwUMXvn5mHqEmXhGmEUwMHvC9MLnAbKRbAHRLsV5pcUFJPnhxJbB4h0S8LuTwZ9AZgXmg0wfK83LyE1MCUtL0zUFHaYF28rEC61gzcJfMzYObgRNoCLDRlldSjFRtuAkysAWARYUYmFLzRBhkHcGFiwLQM8BISc_MB0ZeZrICZAtUpSiDgptriLOHLtys-PQi0CqVeAOorcZiDCzA3nqqBIOCpWmSYaqlZZJ5cpqJiUGipYWBaYphIhAYJpumGKQaSTJI4jRGCo-cPANHgItbvI-nn7c0AxdkTgM0yCjDwFJSVJoqC6waS5LkwL4GAIedbfk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Active+antiangiogenic+therapy&rft.inventor=Romero%2C+M%C3%B3nica+Bequet&rft.inventor=Acevedo+Castro%2C+Boris+Ernesto&rft.inventor=Gavilondo+Cowley%2C+Jorge+Victor&rft.inventor=Fern%C3%A1ndez+Molina%2C+Luis+Enrique&rft.inventor=Ocejo%2C+Omar+Lopez&rft.inventor=Silva+Rodriguez%2C+Ricardo+de+la+Caridad&rft.inventor=Lasa%2C+Alexis+Musachio&rft.inventor=Rodriguez%2C+Ernesto+Galban&rft.inventor=V%C3%A1zquez+Blomquist%2C+Dania+Marcia&rft.number=7556809&rft.date=2009-07-07&rft.externalDBID=n%2Fa&rft.externalDocID=07556809 |